According to the report, global demand for blepharoplasty market was valued at approximately USD 3.83 billion in 2023, and is expected to generate revenue of around USD 7.41 billion by end of 2032, growing at a CAGR of around 7.62% between 2024 and 2032.
Zion Market Research has published a new report titled “Blepharoplasty Market by Type (Combination Eyelid Surgery, Lower Eyelid Blepharoplasty and Upper Eyelid Blepharoplasty); by End User (Specialty Clinics, Ambulatory Surgical Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024– 2032”.
Blepharoplasty is commonly used term for cosmetic surgery that is being used to restore or repair droopy eyelids. This surgery aims to remove excess skin, muscle and fat from droopy eyelids. Aging causes weakening of muscles that support the eyelids. This causes stretching of eyelids as a result of excessive fat deposition leading to sagging eyebrows and droopy eyelids. Blepharoplasty is done to correct the deformities, disfigurations and defects of eyelids. Also, this surgery is used to resolve functional and cosmetic problems of the periorbita. Blepharoplasty is most common in women population.
The global blepharoplasty market growth is fueled by various factors such as increasing inclination to enhance the appearance aesthetically along with growing cognizance about cosmetic procedures. Other factors promoting market growth include growth in number of baby boomers, increasing healthcare spending and disposable income. However, high cost of procedure along with social stigma associated with use of aesthetic procedures in developing nations may restraint market growth during the forecast timeframe. Increasing preference and adoption of minimally invasive surgeries are projected to open new growth avenues for global blepharoplasty market over the forecast period.
The blepharoplasty market is segmented based on end user, type, and region. Based on type, market is categorized into lower eyelid blepharoplasty, upper eyelid blepharoplasty and combination eyelid surgery. In 2023, upper eyelid blepharoplasty type segment held largest revenue share. The excess fat deposition and sagginess is most common in upper eyelids. Thus most common blepharoplasty surgeries are done for upper eyelid accounting for major market share. Highest growth is projected for combination eyelid surgeries in the coming years. Growing adoption and preference for aesthetic surgeries for overall appearance enhancement is expected to act as a driving factor for rapid growth of combination eyelid surgery segment.
Based on end user, market is segmented into specialty clinics, hospitals, ambulatory surgical centers, and other end users. Hospitals held largest market share in 2023. Large share is attributed to easy availability of cutting-edge health care facilities, availability of funds to purchase advanced medical equipment, growing patient pool, easy availability of skilled staff etc. Highest growth is forecasted for specialty clinics end user segment over the forecast period. Growing investments for infrastructure improvement to offer best in class services and growth in number of specialty clinics are factors attributing to fastest growth.
At regional level, North America held largest revenue share of the global blepharoplasty market in 2023. This is due to growing preference and adoption of minimally invasive cosmetic surgeries to improve aesthetic appearance, growing aging and millennial population, easy accessibility to advanced health facilities and growing health spending. Europe was second leading regional blepharoplasty market. Faster adoption of innovative technologies and increasing awareness about cosmetic surgeries are prominent factors that support market growth in Europe. Latin America is expected to showcase steady and moderate growth in the coming years. Asia Pacific region will estimated to exhibit swift growth for blepharoplasty market over the forecasted timeframe. Increasing popularity for eyelid surgeries in China, South Korea, growing demand for cosmetic surgeries, increasing healthcare spending and increasing elderly population are factors that are expected to boost blepharoplasty market growth in Asia Pacific. Moderate growth is projected for Middle East and Africa region in the coming years.
Blepharoplasty Market: Key Players
Major players included in the report are:
- Shoyukai
- Montenegro Clinic of Plastic Surgery
- London Bridge Plastic Surgery
- USA Plastic Surgery
- Stanford Health Care
- GTG Wellness
- Grand Aespio Inc.
- Bomtech Electronics Co. Ltd.
- Advance Medical Systems Inc.
The report segment of global blepharoplasty market as follows:
Global Blepharoplasty Market: By Type
- Upper Eyelid Blepharoplasty
- Lower Eyelid Blepharoplasty
- Combination Eyelid Surgery
Global Blepharoplasty Market: By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centre
- Other End Users
Global Blepharoplasty Market: By Region
- North AmericaU.S.
- EuropeUKFranceGermany
- Asia PacificChinaJapanIndia
- Latin AmericaBrazil
- Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: [email protected] Website: https://www.zionmarketresearch.com
Read More Report-
Atrial Fibrillation Drugs Market
